Connor, Clark & Lunn Investment Management (CC&L)’s Sabra Healthcare REIT SBRA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.3M	Buy	220,632 +87,746	+66%	+$1.74M	0.01%	780
2026 Q1	$2.56M	Sell	132,886 -223,448	-63%	-$4.4M	0.01%	883
2025 Q4	$6.75M	Buy	356,334 +329,198	+1,213%	+$6.1M	0.02%	566
2025 Q3	$506K	Sell	27,136 -208,286	-88%	-$3.89M	﹤0.01%	1257
2025 Q2	$4.34M	Buy	235,422 +199,212	+550%	+$3.54M	0.02%	619
2025 Q1	$633K	Buy	+36,210	New	+$611K	﹤0.01%	1083
2019 Q1	–	Sell	-68,100	Closed	-$1.12M	–	1021
2018 Q4	$1.12M	Buy	+68,100	New	+$1.37M	0.01%	529

Other funds holding SBRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s SBRA Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) increased its Sabra Healthcare REIT (SBRA) stake by 66% in Q2 2026, buying an estimated $1.74M and bringing the position to 220,632 shares worth $4.3M. The position accounts for 0.01% of the portfolio, ranked #780.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in SBRA in Q4 2018 and has held it in 7 quarters since. The position peaked at $6.75M in Q4 2025. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

Connor, Clark & Lunn Investment Management (CC&L) held 220,632 shares of Sabra Healthcare REIT worth $4.3M as of Q2 2026.
Connor, Clark & Lunn Investment Management (CC&L) bought 87,746 Sabra Healthcare REIT shares in Q2 2026, an estimated $1.74M.
Sabra Healthcare REIT made up 0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #780 holding.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Sabra Healthcare REIT in Q4 2018 and has held it in 7 quarters since.
Connor, Clark & Lunn Investment Management (CC&L)'s Sabra Healthcare REIT position peaked at $6.75M in Q4 2025.
463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.